Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?

The maintenance of cholesterol homeostasis is a complicated process involving regulation of cholesterol synthesis, dietary uptake and bile acid synthesis and excretion. Reverse cholesterol transport, described as the transfer of cholesterol from non-hepatic cells, including foam cells in atheroscler...

Full description

Bibliographic Details
Main Author: Malgorzata Sidorkiewicz
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/4/902
_version_ 1797618887572848640
author Malgorzata Sidorkiewicz
author_facet Malgorzata Sidorkiewicz
author_sort Malgorzata Sidorkiewicz
collection DOAJ
description The maintenance of cholesterol homeostasis is a complicated process involving regulation of cholesterol synthesis, dietary uptake and bile acid synthesis and excretion. Reverse cholesterol transport, described as the transfer of cholesterol from non-hepatic cells, including foam cells in atherosclerotic plaques, to the liver and then its excretion in the feces is important part of this regulation. High-density lipoproteins are the key mediators of reverse cholesterol transport. On the other hand, microRNA-33 was identified as a key regulator of cholesterol homeostasis. Recent studies indicate the impact of microRNA-33 not only on cellular cholesterol efflux and HDL production but also on bile metabolism in the liver. As proper coordination of cholesterol metabolism is essential to human health, discussion of recent findings in this field may open new perspectives in the microRNA-dependent treatment of a cholesterol imbalance.
first_indexed 2024-03-11T08:19:55Z
format Article
id doaj.art-6a34fd4cb61044629a6b37b469e47cf2
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T08:19:55Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-6a34fd4cb61044629a6b37b469e47cf22023-11-16T22:30:32ZengMDPI AGNutrients2072-66432023-02-0115490210.3390/nu15040902Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?Malgorzata Sidorkiewicz0Department of Medical Biochemistry, Faculty of Health Sciences, Medical University of Lodz, 90-419 Lodz, PolandThe maintenance of cholesterol homeostasis is a complicated process involving regulation of cholesterol synthesis, dietary uptake and bile acid synthesis and excretion. Reverse cholesterol transport, described as the transfer of cholesterol from non-hepatic cells, including foam cells in atherosclerotic plaques, to the liver and then its excretion in the feces is important part of this regulation. High-density lipoproteins are the key mediators of reverse cholesterol transport. On the other hand, microRNA-33 was identified as a key regulator of cholesterol homeostasis. Recent studies indicate the impact of microRNA-33 not only on cellular cholesterol efflux and HDL production but also on bile metabolism in the liver. As proper coordination of cholesterol metabolism is essential to human health, discussion of recent findings in this field may open new perspectives in the microRNA-dependent treatment of a cholesterol imbalance.https://www.mdpi.com/2072-6643/15/4/902microRNA-33HDLatherosclerosischolesterol effluxreverse cholesterol transportbile acids
spellingShingle Malgorzata Sidorkiewicz
Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
Nutrients
microRNA-33
HDL
atherosclerosis
cholesterol efflux
reverse cholesterol transport
bile acids
title Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
title_full Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
title_fullStr Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
title_full_unstemmed Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
title_short Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
title_sort is microrna 33 an appropriate target in the treatment of atherosclerosis
topic microRNA-33
HDL
atherosclerosis
cholesterol efflux
reverse cholesterol transport
bile acids
url https://www.mdpi.com/2072-6643/15/4/902
work_keys_str_mv AT malgorzatasidorkiewicz ismicrorna33anappropriatetargetinthetreatmentofatherosclerosis